Literature DB >> 21203998

Liberation of SARS-CoV main protease from the viral polyprotein: N-terminal autocleavage does not depend on the mature dimerization mode.

Shuai Chen1, Felix Jonas, Can Shen, Rolf Hilgenfeld, Rolf Higenfeld.   

Abstract

The main protease (M(pro)) plays a vital role in proteolytic processing of the polyproteins in the replicative cycle of SARS coronavirus (SARS-CoV). Dimerization of this enzyme has been shown to be indispensable for trans-cleavage activity. However, the auto-processing mechanism of M(pro), i.e. its own release from the polyproteins through autocleavage, remains unclear. This study elucidates the relationship between the N-terminal autocleavage activity and the dimerization of "immature" M(pro). Three residues (Arg4, Glu290, and Arg298), which contribute to the active dimer conformation of mature M(pro), are selected for mutational analyses. Surprisingly, all three mutants still perform N-terminal autocleavage, while the dimerization of mature protease and trans-cleavage activity following auto-processing are completely inhibited by the E290R and R298E mutations and partially so by the R4E mutation. Furthermore, the mature E290R mutant can resume N-terminal autocleavage activity when mixed with the "immature" C145A/E290R double mutant whereas its trans-cleavage activity remains absent. Therefore, the N-terminal auto-processing of M(pro) appears to require only two "immature" monomers approaching one another to form an "intermediate" dimer structure and does not strictly depend on the active dimer conformation existing in mature protease. In conclusion, an auto-release model of M(pro) from the polyproteins is proposed, which will help understand the auto-processing mechanism and the difference between the autocleavage and trans-cleavage proteolytic activities of SARS-CoV M(pro).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21203998      PMCID: PMC4875104          DOI: 10.1007/s13238-010-0011-4

Source DB:  PubMed          Journal:  Protein Cell        ISSN: 1674-800X            Impact factor:   14.870


  41 in total

1.  Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex.

Authors:  Eric J Snijder; Yvonne van der Meer; Jessika Zevenhoven-Dobbe; Jos J M Onderwater; Jannes van der Meulen; Henk K Koerten; A Mieke Mommaas
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

2.  SARS CoV main proteinase: The monomer-dimer equilibrium dissociation constant.

Authors:  Vito Graziano; William J McGrath; Lin Yang; Walter F Mangel
Journal:  Biochemistry       Date:  2006-12-12       Impact factor: 3.162

3.  Long-range cooperative interactions modulate dimerization in SARS 3CLpro.

Authors:  Jennifer Barrila; Usman Bacha; Ernesto Freire
Journal:  Biochemistry       Date:  2006-12-19       Impact factor: 3.162

4.  The Genome sequence of the SARS-associated coronavirus.

Authors:  Marco A Marra; Steven J M Jones; Caroline R Astell; Robert A Holt; Angela Brooks-Wilson; Yaron S N Butterfield; Jaswinder Khattra; Jennifer K Asano; Sarah A Barber; Susanna Y Chan; Alison Cloutier; Shaun M Coughlin; Doug Freeman; Noreen Girn; Obi L Griffith; Stephen R Leach; Michael Mayo; Helen McDonald; Stephen B Montgomery; Pawan K Pandoh; Anca S Petrescu; A Gordon Robertson; Jacqueline E Schein; Asim Siddiqui; Duane E Smailus; Jeff M Stott; George S Yang; Francis Plummer; Anton Andonov; Harvey Artsob; Nathalie Bastien; Kathy Bernard; Timothy F Booth; Donnie Bowness; Martin Czub; Michael Drebot; Lisa Fernando; Ramon Flick; Michael Garbutt; Michael Gray; Allen Grolla; Steven Jones; Heinz Feldmann; Adrienne Meyers; Amin Kabani; Yan Li; Susan Normand; Ute Stroher; Graham A Tipples; Shaun Tyler; Robert Vogrig; Diane Ward; Brynn Watson; Robert C Brunham; Mel Krajden; Martin Petric; Danuta M Skowronski; Chris Upton; Rachel L Roper
Journal:  Science       Date:  2003-05-01       Impact factor: 47.728

5.  Three-dimensional structure of Escherichia coli glutathione S-transferase complexed with glutathione sulfonate: catalytic roles of Cys10 and His106.

Authors:  M Nishida; S Harada; S Noguchi; Y Satow; H Inoue; K Takahashi
Journal:  J Mol Biol       Date:  1998-08-07       Impact factor: 5.469

6.  High-resolution solution structures of oxidized and reduced Escherichia coli thioredoxin.

Authors:  M F Jeng; A P Campbell; T Begley; A Holmgren; D A Case; P E Wright; H J Dyson
Journal:  Structure       Date:  1994-09-15       Impact factor: 5.006

7.  Enzymatic activity of the SARS coronavirus main proteinase dimer.

Authors:  Vito Graziano; William J McGrath; Ann Marie DeGruccio; John J Dunn; Walter F Mangel
Journal:  FEBS Lett       Date:  2006-04-21       Impact factor: 4.124

8.  Critical assessment of important regions in the subunit association and catalytic action of the severe acute respiratory syndrome coronavirus main protease.

Authors:  Wen-Chi Hsu; Hui-Chuan Chang; Chi-Yuan Chou; Pui-Jen Tsai; Pei-In Lin; Gu-Gang Chang
Journal:  J Biol Chem       Date:  2005-04-14       Impact factor: 5.157

9.  Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage.

Authors:  Eric J Snijder; Peter J Bredenbeek; Jessika C Dobbe; Volker Thiel; John Ziebuhr; Leo L M Poon; Yi Guan; Mikhail Rozanov; Willy J M Spaan; Alexander E Gorbalenya
Journal:  J Mol Biol       Date:  2003-08-29       Impact factor: 5.469

10.  The catalysis of the SARS 3C-like protease is under extensive regulation by its extra domain.

Authors:  Jiahai Shi; Jianxing Song
Journal:  FEBS J       Date:  2006-03       Impact factor: 5.542

View more
  27 in total

1.  Chimeric exchange of coronavirus nsp5 proteases (3CLpro) identifies common and divergent regulatory determinants of protease activity.

Authors:  Christopher C Stobart; Nicole R Sexton; Havisha Munjal; Xiaotao Lu; Katrina L Molland; Sakshi Tomar; Andrew D Mesecar; Mark R Denison
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

2.  Discovery, synthesis, and structure-based optimization of a series of N-(tert-butyl)-2-(N-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus (SARS-CoV) 3CL protease.

Authors:  Jon Jacobs; Valerie Grum-Tokars; Ya Zhou; Mark Turlington; S Adrian Saldanha; Peter Chase; Aimee Eggler; Eric S Dawson; Yahira M Baez-Santos; Sakshi Tomar; Anna M Mielech; Susan C Baker; Craig W Lindsley; Peter Hodder; Andrew Mesecar; Shaun R Stauffer
Journal:  J Med Chem       Date:  2013-01-03       Impact factor: 7.446

3.  SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity.

Authors:  Tomonari Muramatsu; Chie Takemoto; Yong-Tae Kim; Hongfei Wang; Wataru Nishii; Takaho Terada; Mikako Shirouzu; Shigeyuki Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-31       Impact factor: 11.205

Review 4.  Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.

Authors:  Stefanie Reis; Maria-Inti Metzendorf; Rebecca Kuehn; Maria Popp; Ildiko Gagyor; Peter Kranke; Patrick Meybohm; Nicole Skoetz; Stephanie Weibel
Journal:  Cochrane Database Syst Rev       Date:  2022-09-20

5.  Interactive Molecular Dynamics in Virtual Reality Is an Effective Tool for Flexible Substrate and Inhibitor Docking to the SARS-CoV-2 Main Protease.

Authors:  Helen M Deeks; Rebecca K Walters; Jonathan Barnoud; David R Glowacki; Adrian J Mulholland
Journal:  J Chem Inf Model       Date:  2020-11-11       Impact factor: 4.956

6.  Dynamically-driven inactivation of the catalytic machinery of the SARS 3C-like protease by the N214A mutation on the extra domain.

Authors:  Jiahai Shi; Nanyu Han; Liangzhong Lim; Shixiong Lua; J Sivaraman; Lushan Wang; Yuguang Mu; Jianxing Song
Journal:  PLoS Comput Biol       Date:  2011-02-24       Impact factor: 4.475

7.  Purification, crystallization and preliminary X-ray analysis of nonstructural protein 2 (nsp2) from avian infectious bronchitis virus.

Authors:  Kun Yu; Zhenhua Ming; Yuanyuan Li; Cheng Chen; Zehua Bao; Zhilin Ren; Bofeng Liu; Wei Tao; Zihe Rao; Zhiyong Lou
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-05-24

8.  Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screenings.

Authors:  Hyun Lee; Anuradha Mittal; Kavankumar Patel; Joseph L Gatuz; Lena Truong; Jaime Torres; Debbie C Mulhearn; Michael E Johnson
Journal:  Bioorg Med Chem       Date:  2013-12-01       Impact factor: 3.641

Review 9.  A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process.

Authors:  G D Noske; A M Nakamura; V O Gawriljuk; R S Fernandes; G M A Lima; H V D Rosa; H D Pereira; A C M Zeri; A F Z Nascimento; M C L C Freire; D Fearon; A Douangamath; F von Delft; G Oliva; A S Godoy
Journal:  J Mol Biol       Date:  2021-06-24       Impact factor: 6.151

10.  Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS.

Authors:  Sakshi Tomar; Melanie L Johnston; Sarah E St John; Heather L Osswald; Prasanth R Nyalapatla; Lake N Paul; Arun K Ghosh; Mark R Denison; Andrew D Mesecar
Journal:  J Biol Chem       Date:  2015-06-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.